Articles

Pediatric Vs Adult MDS

By Prof. Dr. Charlotte Niemeyer

Klinik für Pädiatrische Hämatologie und Onkologie, Zentrum für Kinder- und Jugendmedizin, Universitätsklinikum Freiburg, Mathildhenstrasse 1, Freiburg, Germany

(This lecture was delivered during the webseries: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Monday, 4th July 2022)


Molecular profiling in DLBCL-challenges and opportunities

By Dr Daniel Hodson

CRUK Senior Research Fellow, Honorary Consultant Haematologist, Wellcome-MRC Cambridge Stem Cell Institute
University of Cambridge, Department of Haematology, The Jeffrey Cheah Biomedical Centre, Cambridge, UK

(This lecture was delivered during the webseries: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Monday, 4th July 2022)


What is new in the treatment of MPNs in 2022?

By Dr. Haifa Kathrin Al-Ali, MD

Professor, The department of Hematology and Medical Oncology
The University Hospital of Halle, Germany

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Thursday, 7th July 2022)


Toxicities in ALL due to host factors - can we prevent them?

By Dr. Kjeld Schmiegelow

Professor in Pediatrics and Pediatric Oncology
Department of Pediatrics and Adolescent Medicine
The Juliane Marie Centre, Rigshospitalet
Copenhagen University Hospital, Copenhagen, Denmark

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Saturday, 9th July 2022)


Managing chronic myeloid leukaemia in 2022

By Dr. Jeffrey H Lipton, PhD, MD, FRCPC

Professor of Medicine, University of Toronto
Staff Physician, Leukaemia and Allogeneic Stem Cell Transplant Services
Princess Margaret Cancer Centre, Toronto, ON, Canada

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Sunday, 10th July 2022)


2022 Review of Follicular Lymphoma

By Dr. Tycel J. Phillips, MD

Maria Reinhardt Decesare Research Professor of Blood Cancers and Bone Marrow Transplantation, Rogel Cancer Center, University of Michigan, Michigan, USA

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Sunday, 10th July 2022)


Laboratory diagnosis and interpretation of coagulation disorders

By Dr. János Kappelmayer

Dept of Laboratory Medicine, Faculty of Medicine, University of Debrecen
Hungary

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Friday, 8th July 2022)


Mantle Cell Lymphoma

By Dr. Kami Maddocks, MD

Professor , Lymphoma Program Director,The James Cancer Hospital
The Ohio State University, Columbus, Ohio

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Wednesday, 6th July 2022)


Acquired Hemostasis Disorders (acquired hemophilia, acquired VWD & others)

By Dr. Andreas Tiede, MD, PhD

Professor of Haemostasis and Thrombosis
Hannover Medical School, Dept. Hematology, Hemostasis,
Oncology and Stem Cell Transplantation, Hannover, Germany

(This lecture was delivered during the web series: Challenges in hematology - Best of 22nd Annual conference of European Hematology Association i.e., EHA, Friday, 8th July 2022)